Skip to content

The Efficacy of CT-guided dorsal root ganglion injection of platelet-rich plasma combined with pulsed radiofrequency in the treatment of herpes zoster neuralgia

The Efficacy analysis of CT-guided dorsal root ganglion injection of platelet-rich plasma combined with pulsed radiofrequency in the treatment of herpes zoster neuralgia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078037
Enrollment
Unknown
Registered
2023-11-27
Start date
2022-06-20
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster neuralgia

Interventions

Pulsed Radiofrequency Group :Pulsed Radiofrequency
Platelet-rich Plasma Pulsed combine with RadiofrequencyGroup :Platelet-rich Plasma Pulsed combine with Radiofrequency

Sponsors

The Affiliated Hospital of Jiaxing University / The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? clear diagnosis of herpes zoster neuralgia; ? preoperative NRS score?5; ? age?18 years; ? disease duration within one month; ? agree to CT-guided dorsal root ganglion injection of platelet-rich plasma combined with pulsed radiofrequency treatment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) those with previous treatments such as radiofrequency therapy or neurodesis; (2) those with skin infection at the puncture site; (3) those with chronic liver disease and those undergoing anticoagulation therapy; (4) those with complications of geriatric diabetes, especially those with clinical symptoms such as itching and pain due to concomitant peripheral neuritis; (5) those allergic to or abusing neurotrophic and analgesic drugs in the experiment; (6) those with previous sleep disorders; (7) those with combined severe hypertension, recent myocardial infarction, and moderate to severe abnormalities in liver and kidney function; (8) those with mental illness or cognitive dysfunction who cannot fully understand the scoring scale.

Design outcomes

Primary

MeasureTime frame
Numeric rating scores;

Secondary

MeasureTime frame
The incidence of postherpetic neuralgia;Quality of sleep;Mental state;drug dose;Patients' satisfaction;

Countries

China

Contacts

Public ContactLing Ma

The Affiliated Hospital of Jiaxing University / The First Hospital of Jiaxing

1319108@qq.com+86 198 8337 2886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026